Amylyx Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Amylyx Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • Amylyx Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -46.2 %, a 93.9% decline year-over-year.
  • Amylyx Pharmaceuticals, Inc. annual Return On Equity for 2023 was 12.4 %.
  • Amylyx Pharmaceuticals, Inc. annual Return On Equity for 2022 was -86.4 %, a 212% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -46.2 -22.4 -93.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -18.2 +39.6 +68.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 12.4 +98.8 Oct 1, 2023 Dec 31, 2023
Q3 2023 0.49 +173 Jul 1, 2023 Sep 30, 2023
Q2 2023 -23.8 +363 +93.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -57.8 -414 -116% Jan 1, 2023 Mar 31, 2023
Q4 2022 -86.4 -163 -212% Oct 1, 2022 Dec 31, 2022
Q3 2022 -173 Jul 1, 2022 Sep 30, 2022
Q2 2022 -387 Apr 1, 2022 Jun 30, 2022
Q1 2022 356 Jan 1, 2022 Mar 31, 2022
Q4 2021 76.8 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.